Contact

Clear Almanac 74 welcomes corrections, questions, and feedback about site content. Our goal is to keep the resource accurate, transparent, and useful.

Independent
Evidence-first resource
No clinic claims
Not a provider or medical advice

If you are looking for editorial methodology or sourcing, see our statement on the site's approach in the About section.

For corrections and editorial queries we ask readers to consult the editorial overview on our About page where guidance on submitting evidence and corrections is described.

To navigate back to the main collection of topics, visit the site's landing overview overview and listings.

How to reach us

At present there is no public email or contact form published for Clear Almanac 74. If you need to propose a correction, share sourcing, or raise a concern, please check back for updated contact details and submission instructions; our editorial approach and channels are described on the About page.

We also publish contextual notes and updates on our site index; to return to that starting point, use the site directory available from the main landing overview.

Disclosure

Sable Switch is an independent information resource, not a clinic, medical provider, or licensed treatment center. Its content is not medical or legal advice.

Editorial material elsewhere on the site references treatment-centre discussion and patient experiences; for facility listings readers sometimes consult external directories such as the ibogaine treatment centers overview at ibogaine treatment centers USA.

Background explainers on program models often link to primer pages like what is an ibogaine treatment for high-level orientation.

Readers seeking commentary on reported benefits sometimes follow analyses such as ibogaine benefits, while neuroscience overviews are occasionally cross-referenced with pages like ibogaine neuroplasticity.

International retreat reporting that appears in profile pieces can point to specific provider pages such as ibogaine Mexico retreats, and material assessing anti-addiction claims may reference resources like ibogaine anti-addiction evaluations.

For readers seeking third-party authoritative context about treatment safety and regulated frameworks, reputable sources include clinical summaries on Wikipedia's ibogaine overview, safety and regulatory guidance hosted by official health agencies such as the U.S. Food and Drug Administration (fda.gov), and university-hosted harm-reduction research pages like those at Johns Hopkins University (jhu.edu).